Testing a new patch for bone loss and joint pain
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests a small patch with a needle that delivers a medicine called denosumab through the skin. It is for healthy people or those with osteoarthritis and osteoporosis, to check if the patch is safe for the skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 70
- Be healthy or have osteoarthritis along with osteoporosis
- No current skin conditions or other significant illnesses
- No use of certain medications (like allergy, blood thinning, or hormone drugs) in the last month
- If you can become pregnant, use birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
This study tests whether denosumab, a medication given as an injection, can help prevent broken bones in people with type 2 diabetes who are at high risk for fractures. It aims to see if this treatment can strengthen bones and reduce fracture risk.
This study tests a new form of calcium (amorphous calcium carbonate) to see if it can improve bone density in postmenopausal women with osteoporosis. It may offer an alternative for women who cannot or choose not to take other osteoporosis medications.
This study looks at how well and how safely another osteoporosis medicine works for people who have already taken denosumab for 2 years. It may help find the best next step to strengthen bones and lower fracture risk after denosumab.
This study tests a new version of a medicine called abaloparatide (used for bone health) to see if it works the same as the approved version (Tymlos). It is for healthy adults aged 40–65 who are willing to stay at the clinic for a few days and have blood tests.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.